What is Myriad Genetics's accrued royalties (current)?

Myriad Genetics (MYGN) reported accrued royalties (current) of $4.7M in Q1 2026.

How has Myriad Genetics's accrued royalties (current) changed year-over-year?

Myriad Genetics's accrued royalties (current) decreased by 21.7% year-over-year, from $6M to $4.7M.

What is the long-term trend for Myriad Genetics's accrued royalties (current)?

Over 5 years (2020 to 2025), Myriad Genetics's accrued royalties (current) has grown at a 4.3% compound annual growth rate (CAGR), from $3.8M to $4.7M.

Myriad Genetics MYGN Accrued Royalties (Current)

Accrued Royalties (Current) at other companies

Reservoir Media, Inc.RSVR

$52.32M+10.8%

ScholasticSCHL

$82.3M-3.3%

HTF

Heartflow, Inc. Common StockHTFL

$1.05M—

HealthStreamHSTM

$6.59M+17.3%

Warrior Met CoalHCC

$8.84M+22.7%

Inter ParfumsIPAR

$29.34M+7.9%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:AccruedRoyaltiesCurrent.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's accrued royalties (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's accrued royalties (current)?: Myriad Genetics (MYGN) reported accrued royalties (current) of $4.7M in Q1 2026.
How has Myriad Genetics's accrued royalties (current) changed year-over-year?: Myriad Genetics's accrued royalties (current) decreased by 21.7% year-over-year, from $6M to $4.7M.
What is the long-term trend for Myriad Genetics's accrued royalties (current)?: Over 5 years (2020 to 2025), Myriad Genetics's accrued royalties (current) has grown at a 4.3% compound annual growth rate (CAGR), from $3.8M to $4.7M.